Am. J. Respir. Crit. Care Med., Vol 152, No. 6, Dec 1995, 1796-1804.
Characterization of neurogenic inflammation in the airways of two highly inbred rat strains
PR Germonpre, GF Joos, E Everaert, JC Kips and RA Pauwels
Department of Respiratory Diseases, University of Ghent, Belgium.
Tachykinins released from sensory airway nerves have been shown to increase
vascular permeability and plasma-protein extravasation (PPE) in rodent
airways. We previously demonstrated that in Fisher (F344) rats, tachykinins
cause bronchoconstriction mainly by indirect mechanisms involving the
activation of NK1 receptor and mast cells, whereas in the less responsive
BDE rats tachykinins have a direct NK2 receptor-mediated effect on
bronchial smooth muscle. Using Evans blue dye as an intravascular marker,
we demonstrated that F344 rats are hyperresponsive for the PPE induced by
substance P (SP) and capsaicin. The NK1 receptor antagonist RP 67,580
reduced the neurogenic PPE in both strains, whereas the NK2 receptor
antagonist SR 48,968 had no effect, indicating that only NK1 receptors are
involved in the PPE. Pretreatment with the 5-HT antagonist methysergide
decreased the neurogenic PPE in F344 rats but not in BDE rats. In F344 rats
depleted of mast-cell mediators with compound 48/80, the SP-induced PPE was
significantly reduced. Pretreatment with the H1 antagonist mepyramine and
the H2 antagonist cimetidine caused a similar reduction in SP- induced PPE
in main bronchi of both strains. Pretreatment with atropine, indomethacin,
or the leukotriene antagonist ICI 198,615 did not affect the SP-induced
PPE. In conclusion, neurogenic PPE in rat airways involves the activation
of NK1 receptors. In F344 but not in BDE rats, an additional indirect
mechanism involving 5-HT release and mast-cell activation participates in
the neurogenic PPE.